Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis

BACKGROUND AND AIMS: Utilization and safety of cannabidiol (CBD) in patients with autoimmune hepatitis (AIH) are currently unknown. We aimed to identify the frequency of CBD use, impact on symptoms, and safety profile. METHODS: An invitation to complete a CBD-specific questionnaire was posted every...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathur, Karan, Vuppalanchi, Vahin, Gelow, Kayla, Vuppalanchi, Raj, Lammert, Craig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943405/
https://www.ncbi.nlm.nih.gov/pubmed/31363952
http://dx.doi.org/10.1007/s10620-019-05756-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943405/
https://www.ncbi.nlm.nih.gov/pubmed/31363952
http://dx.doi.org/10.1007/s10620-019-05756-7

Ejemplares similares